MGC pharma completes acquisition of telehealth platform MCC
Filed with ASX · · 2 pages · English
Story so far
Earlier from Argent Biopharma
- Further successful results from glioblastoma research
- Completion of phase II clinical trial on COVID-19 patients
- September Quarterly Activity and Cashflow Report
- Mgc pharma delivers record consecutive weekly sales growth
- ArtemiC histology on rats confirm no pathological impact
Later from Argent Biopharma
- Prospectus
- ArtemiC Phase II Clinical Trial Results
- December Quarterly Activity and Cashflow Report
- MGC Pharma Investor Presentation
- MGC Pharma first medicinal cannabis company to list on LSE
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma